ArticleFrontiers in oncology2025

Intensifying adjuvant therapy in intermediate-risk head and neck cancer: navigating the gray zone, selecting the right patient.

Samarpita Mohanty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.